Advertisement

Brain Tumor Pathology

, Volume 35, Issue 1, pp 36–40 | Cite as

Enchondromatosis-associated oligodendroglioma: case report and literature review

  • Takamune Achiha
  • Hideyuki Arita
  • Naoki Kagawa
  • Tsuyoshi Murase
  • Jun-ichiro Ikeda
  • Eiichi Morii
  • Yonehiro Kanemura
  • Yasunori Fujimoto
  • Haruhiko Kishima
Case Report

Abstract

Enchondromatosis is a rare skeletal disorder characterized by the development of multiple enchondromas, which can also manifest non-cartilage tumors including gliomas. Here, we describe a genetic analysis of a low-grade glioma that developed in an enchondromatosis case. A 32-year-old man with a long history of enchondromatosis developed a left frontal tumor. The histopathological findings of his surgical specimen revealed characteristics of a low-grade glioma with an IDH1 c.395G>A (R132H) mutation and 1p/19q codeletion, which led to a definitive diagnosis of oligodendroglioma. A common point mutation in IDH1 (R132H) was detected in the patient’s enchondroma and glioma-matched pair specimens. To the best of our knowledge, this is the first case of molecularly confirmed oligodendroglioma associated with enchondromatosis. Furthermore, identification of a common IDH1 mutation in enchondroma and oligodendroglioma-matched pair specimens supports the hypothesis that IDH1/2 mosaicism initiates tumorigenesis.

Keywords

Enchondromatosis Oligodendroglioma 1p/19q codeletion IDH1/2 mosaicism 

Notes

Acknowledgements

This work was supported by JSPS KAKENHI Grant Number 16K20006 (H.A.). The authors thank Ms. Ema Yoshioka, Mr. Daisuke Kanematsu, and Ms. Tomoko Shofuda (Institute for Clinical Research, Osaka National Hospital) for generous assistance in genetic tests.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Pansuriya TC, Kroon HM, Bovée JVMG. (2010) Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol 3:557–569PubMedPubMedCentralGoogle Scholar
  2. 2.
    Schwartz HS, Zimmerman NB, Simon MA et al (1987) The malignant potential of enchondromatosis. J Bone Jt Surg Am 69:269–274CrossRefGoogle Scholar
  3. 3.
    Lewis RJ, Ketcham AS (1973) Maffucci’s syndrome: functional and neoplastic significance. J Bone Jt Surg Am 55:1465–1479.  https://doi.org/10.2106/00004623-197355070-00014 CrossRefGoogle Scholar
  4. 4.
    White MS, Martin PL, McLean TW (2008) Acute myelogenous leukemia associated with Ollier disease. Pediatr Blood Cancer 50:645–646.  https://doi.org/10.1002/pbc.21050 CrossRefPubMedGoogle Scholar
  5. 5.
    Amary MF, Damato S, Halai D et al (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43:1262–1265.  https://doi.org/10.1038/ng.994 CrossRefPubMedGoogle Scholar
  6. 6.
    Pansuriya TC, van Eijk R, d’Adamo P et al (2011) Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 43:1256–1261.  https://doi.org/10.1038/ng.1004 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739–744.  https://doi.org/10.1038/nature08617 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Dang L, Su S-SM (2017) Isocitrate dehydrogenase mutation and (R)-2-hydroxyglutarate: from basic discovery to therapeutics development. Annu Rev Biochem 86:305–331.  https://doi.org/10.1146/annurev-biochem-061516-044732 CrossRefPubMedGoogle Scholar
  9. 9.
    Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812.  https://doi.org/10.1126/science.1164382 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ichimura K, Pearson DM, Kocialkowski S et al (2009) IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro-Oncology 11:341–347.  https://doi.org/10.1215/15228517-2009-025 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Bonnet C, Thomas L, Psimaras D et al (2016) Characteristics of gliomas in patients with somatic IDH mosaicism. Acta Neuropathol Commun 4:31.  https://doi.org/10.1186/s40478-016-0302-y CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bathla G, Gupta S, Ong CK (2012) Multifocal intracranial astrocytoma in a pediatric patient with Ollier disease. Indian J Radiol Imaging 22:58–62.  https://doi.org/10.4103/0971-3026.95406 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Pearce P, Robertson T, Ortiz-Gomez JD et al (2012) Multifocal supratentorial diffuse glioma in a young patient with Ollier disease. J Clin Neurosci 19:477–478.  https://doi.org/10.1016/j.jocn.2011.06.019 CrossRefPubMedGoogle Scholar
  14. 14.
    Moriya K, Kaneko MK, Liu X et al (2014) IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome. Cancer Sci 105:359–362.  https://doi.org/10.1111/cas.12337 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Arita H, Yamasaki K, Matsushita Y et al (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4:79.  https://doi.org/10.1186/s40478-016-0351-2 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO clasification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon (Revised)Google Scholar
  17. 17.
    Mardis ER, Ding L, Dooling DJ et al (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058–1066.  https://doi.org/10.1056/NEJMoa0903840 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Amary MF, Bacsi K, Maggiani F et al (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224:334–343.  https://doi.org/10.1002/path.2913 CrossRefPubMedGoogle Scholar
  19. 19.
    Borger DR, Tanabe KK, Fan KC et al (2012) Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17:72–79.  https://doi.org/10.1634/theoncologist.2011-0386 CrossRefPubMedGoogle Scholar
  20. 20.
    Prokopchuk O, Andres S, Becker K et al (2016) Maffucci syndrome and neoplasms: a case report and review of the literature. BMC Res Notes 9:126.  https://doi.org/10.1186/s13104-016-1913-x CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Publ Group 47:458–468.  https://doi.org/10.1038/ng.3273 Google Scholar

Copyright information

© The Japan Society of Brain Tumor Pathology 2017

Authors and Affiliations

  • Takamune Achiha
    • 1
  • Hideyuki Arita
    • 1
  • Naoki Kagawa
    • 1
  • Tsuyoshi Murase
    • 2
  • Jun-ichiro Ikeda
    • 3
  • Eiichi Morii
    • 3
  • Yonehiro Kanemura
    • 4
    • 5
  • Yasunori Fujimoto
    • 1
  • Haruhiko Kishima
    • 1
  1. 1.Department of NeurosurgeryOsaka University Graduate School of MedicineSuitaJapan
  2. 2.Department of Orthopedic SurgeryOsaka University Graduate School of MedicineOsakaJapan
  3. 3.Department of PathologyOsaka University Graduate School of MedicineOsakaJapan
  4. 4.Division of Regenerative Medicine, Institute for Clinical ResearchOsaka National Hospital, National Hospital OrganizationOsakaJapan
  5. 5.Kansai Molecular Diagnosis Network for Central Nervous System TumorsOsakaJapan

Personalised recommendations